Skip to main content
Premium Trial:

Request an Annual Quote

CIA-Founded Non-Profit Invests in OpGen to Develop Microbial-Analysis Tech

NEW YORK (GenomeWeb News) — Microbial genomics company OpGen today said it has received an undisclosed investment from In-Q-Tel, a non-profit launched by the US Central Intelligence Agency that invests in technologies "of importance to the intelligence community."
 
In a statement describing the investment, In-Q-Tel said that OpGen’s microbial genome-analysis technology will “significantly improve the user's ability to analyze organisms.”
 
The investment fits OpGen’s “move towards delivering stand-alone instruments and disposables for microbial analysis,” OpGen CSO Colin Dykes said in the statement.
 
The investment comes one month after OpGen closed a Series A funding round worth $23.6 million.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.